IIM
INTECH Investment Management Portfolio holdings
AUM
$10.7B
1-Year Return
23.47%
This Quarter Return
+15.26%
1 Year Return
+23.47%
3 Year Return
+97.82%
5 Year Return
–
10 Year Return
–
AUM
$10.7B
AUM Growth
+$949M
(+9.8%)
Cap. Flow
-$169M
Cap. Flow
% of AUM
-1.59%
Top 10 Holdings %
Top 10 Hldgs %
26.63%
Holding
2,728
New
207
Increased
842
Reduced
1,314
Closed
281
Top Buys
| 1 |
Targa Resources
TRGP
|
+$35.2M |
| 2 |
General Motors
GM
|
+$29.6M |
| 3 |
CBRE Group
CBRE
|
+$28.1M |
| 4 |
FedEx
FDX
|
+$27.3M |
| 5 |
Booking.com
BKNG
|
+$24M |
Top Sells
| 1 |
Merck
MRK
|
+$37.9M |
| 2 |
DexCom
DXCM
|
+$36M |
| 3 |
Iron Mountain
IRM
|
+$32.1M |
| 4 |
Walt Disney
DIS
|
+$23.1M |
| 5 |
Hewlett Packard
HPE
|
+$22M |
Sector Composition
| 1 | Technology | 28.62% |
| 2 | Financials | 13.47% |
| 3 | Consumer Discretionary | 12.32% |
| 4 | Healthcare | 10.38% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Aura Biosciences
AURA
$401M
| $129K | ﹤0.01% |
20,585
-5,154
| -20% | -$32.3K |
|
2227
Viemed Healthcare
VMD
$256M
| $129K | ﹤0.01% |
18,612
+2,349
| +14% | +$16.2K |
|
2228
Sky Harbour Group
SKYH
$339M
| $128K | ﹤0.01% |
+13,144
| New | +$128K |
|
|
ZBIO
2229
Zenas BioPharma, Inc. Common Stock
ZBIO
$874M
| $128K | ﹤0.01% |
13,206
+1,607
| +14% | +$15.6K |
|
2230
Inspired Entertainment
INSE
$248M
| $127K | ﹤0.01% |
15,599
-233
| -1% | -$1.9K |
|
2231
Annexon
ANNX
$258M
| $126K | ﹤0.01% |
52,699
-14,566
| -22% | -$35K |
|
2232
Eventbrite
EB
$262M
| $126K | ﹤0.01% |
48,033
-3,810
| -7% | -$10K |
|
2233
Playtika
PLTK
$1.4B
| $126K | ﹤0.01% |
+26,639
| New | +$126K |
|
2234
ON24
ONTF
$231M
| $125K | ﹤0.01% |
23,042
+4,809
| +26% | +$26.1K |
|
2235
Asure Software
ASUR
$219M
| $125K | ﹤0.01% |
12,776
-2,477
| -16% | -$24.2K |
|
2236
American Coastal Insurance
ACIC
$527M
| $124K | ﹤0.01% |
11,122
-3,057
| -22% | -$34K |
|
|
ACRE
2237
Ares Commercial Real Estate
ACRE
$269M
| $124K | ﹤0.01% |
25,919
-6,198
| -19% | -$29.6K |
|
2238
ZimVie
ZIMV
$532M
| $123K | ﹤0.01% |
13,139
-4,902
| -27% | -$45.8K |
|
2239
908 Devices
MASS
$204M
| $123K | ﹤0.01% |
+17,187
| New | +$123K |
|
2240
Rocket Pharmaceuticals
RCKT
$344M
| $122K | ﹤0.01% |
49,990
+1,272
| +3% | +$3.12K |
|
2241
Vanda Pharmaceuticals
VNDA
$266M
| $122K | ﹤0.01% |
25,763
-11,368
| -31% | -$53.7K |
|
2242
Cerus
CERS
$226M
| $121K | ﹤0.01% |
85,988
-66,642
| -44% | -$94K |
|
2243
Kopin
KOPN
$340M
| $121K | ﹤0.01% |
+79,190
| New | +$121K |
|
2244
Esperion Therapeutics
ESPR
$512M
| $121K | ﹤0.01% |
123,040
+28,695
| +30% | +$28.2K |
|
2245
Gossamer Bio
GOSS
$700M
| $121K | ﹤0.01% |
+98,303
| New | +$121K |
|
2246
8x8 Inc
EGHT
$286M
| $121K | ﹤0.01% |
61,657
+508
| +0.8% | +$996 |
|
2247
Candel Therapeutics
CADL
$266M
| $121K | ﹤0.01% |
23,871
-4,695
| -16% | -$23.8K |
|
2248
E.W. Scripps
SSP
$245M
| $120K | ﹤0.01% |
40,853
+21,842
| +115% | +$64.2K |
|
2249
Satellogic
SATL
$379M
| $120K | ﹤0.01% |
+33,068
| New | +$120K |
|
2250
Abeona Therapeutics
ABEO
$347M
| $120K | ﹤0.01% |
+21,049
| New | +$120K |
|